Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-14 Purchase |
2020-08-18 6:19 pm |
Unum Therapeutics Inc. | UMRX | Venrock Healthcare Capital Partners III L.P. Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Co-Investment Holdings III LLC VHCP Management II LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
451,000 | $2.5213 | $1,137,120 | 4,355,273 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-01 Option Award |
2021-04-05 9:09 pm |
N/A 2031-04-01 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,121 | $5.6577 | 2,121 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 9:06 pm |
N/A 2031-04-01 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,068 | $5.6557 | 2,068 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 8:44 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | Harwin Peter Evan Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 7:05 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 7:00 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | Shegog Todd Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 7:00 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 7:00 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | CAIN CHRISTOPHER W. Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 6:54 pm |
N/A 2031-03-11 |
Cogent Biosciences Inc. | COGT | Morris Arlene Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:56 pm |
N/A N/A |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
524 | $0 | 21,654 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 6:36 pm |
N/A 2031-02-22 |
Cogent Biosciences Inc. | COGT | Shegog Todd Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:17 pm |
N/A 2031-02-10 |
Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO |
315,200 | $0 | 315,200 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:17 pm |
N/A 2031-02-10 |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
382,046 | $0 | 382,046 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:11 pm |
N/A 2031-02-10 |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
126,500 | $0 | 126,500 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 8:19 pm |
N/A 2031-02-01 |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:48 pm |
N/A 2031-01-04 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
1,641 | $0 | 1,641 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:47 pm |
N/A 2031-01-04 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
1,575 | $0 | 1,575 (Direct) |
View |
| 2020-12-07 Option Award |
2020-12-09 9:09 pm |
N/A 2030-12-07 |
Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO |
456,693 | $0 | 456,693 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-07 2:41 pm |
N/A N/A |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
1,748 | $0 | 1,748 (Direct) |
View |
| 2020-10-23 Option Award |
2020-10-27 4:05 pm |
N/A 2030-10-22 |
Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO |
7,442,421 | $0 | 7,442,421 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:20 pm |
N/A 2030-10-12 |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
695,700 | $0 | 695,700 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 5:30 pm |
N/A 2030-10-01 |
Unum Therapeutics Inc. | UMRX | Ferrante Karen Jean Director |
8,878 | $1.3518 | 8,878 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 5:30 pm |
N/A 2030-10-01 |
Unum Therapeutics Inc. | UMRX | Ros Matthew Director |
9,247 | $1.3518 | 9,247 (Direct) |
View |
| 2020-08-27 Option Award |
2020-08-31 1:08 pm |
N/A 2030-08-27 |
Unum Therapeutics Inc. | UMRX | Harwin Peter Evan Director |
28,661 | $0 | 28,661 (Direct) |
View |
| 2020-08-27 Option Award |
2020-08-31 1:01 pm |
N/A 2030-08-27 |
Unum Therapeutics Inc. | UMRX | CAIN CHRISTOPHER W. Director |
28,661 | $0 | 28,661 (Direct) |
View |
Ownership |
2020-08-18 5:20 pm |
N/A N/A |
Unum Therapeutics Inc. | UMRX | Venrock Healthcare Capital Partners III L.P. Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC VHCP Co-Investment Holdings III LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
0 | $0 | 17,540,273 (Indirect) |
View |
| 2020-07-06 Exercise |
2020-07-08 7:40 pm |
N/A N/A |
Unum Therapeutics Inc. | UMRX | Green John L. Chief Financial Officer |
109,459 | $0 | 77,586 (Direct) |
View |
| 2020-07-06 Tax Withholding |
2020-07-08 7:40 pm |
N/A N/A |
Unum Therapeutics Inc. | UMRX | Green John L. Chief Financial Officer |
31,873 | $2.2 | 77,586 (Direct) |
View |
| 2020-07-06 Other |
2020-07-08 7:29 pm |
N/A N/A |
Unum Therapeutics Inc. | UMRX | Fairmount Funds Management LLC 10% Owner |
6,280,590 | $0 | 11,369,087 (Indirect) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:52 pm |
N/A 2030-07-01 |
Unum Therapeutics Inc. | UMRX | Booth Bruce Director |
61,338 | $0.3118 | 61,338 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:27 pm |
N/A 2030-07-01 |
Unum Therapeutics Inc. | UMRX | Ros Matthew Director |
35,280 | $0.3118 | 35,280 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:27 pm |
N/A 2030-07-01 |
Unum Therapeutics Inc. | UMRX | Ferrante Karen Jean Director |
38,487 | $0.3118 | 38,487 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-06 4:15 pm |
N/A 2030-07-01 |
Unum Therapeutics Inc. | UMRX | Aldag Jorn Director |
40,090 | $0.3118 | 40,090 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-11 4:25 pm |
N/A 2030-06-09 |
Unum Therapeutics Inc. | UMRX | Ros Matthew Director |
14,331 | $0 | 14,331 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-11 4:24 pm |
N/A 2030-06-09 |
Unum Therapeutics Inc. | UMRX | Morris Arlene Director |
14,331 | $0 | 14,331 (Direct) |
View |